U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


CZEREPAK ELIZABETH (0001263500)
Mailing Address
201 ROUTE 17 NORTH
RUTHERFORD NJ 07070
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Vickers Vantage Corp. I
Current Name:Scilex Holding Co		 0001820190 2022-11-10 officer: See Remarks
Sorrento Therapeutics, Inc. 0000850261 2021-11-15 director
DELCATH SYSTEMS, INC. 0000872912 2020-11-23 director
SPECTRUM PHARMACEUTICALS INC 0000831547 2019-06-19 director
PHARMATHENE, INC
Current Name:Altimmune, Inc.		 0001326190 2017-05-04 officer: See Remarks
CANCER GENETICS, INC
Current Name:Vyant Bio, Inc.		 0001349929 2013-04-04 officer: Chief Financial Officer
AFFYMAX INC 0001158223 2006-12-14 director, 10 percent owner
MiddleBrook Pharmaceuticals, Inc. 0001161924 2003-10-15 director


Items 1 - 48

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-05-23   DELCATH SYSTEMS, INC. 4 A-Award --D 22500.0000 22500.0000 1 0000872912 Stock Option (right to buy)
A 2023-06-12   DELCATH SYSTEMS, INC. 4 A-Award --D 19682.0000 19682.0000 1 0000872912 Stock Option (Right to Buy)
A 2023-01-17   Scilex Holding Co 4 A-Award --D 350000.0000 350000.0000 1 0001820190 Nonstatutory Stock Option (right to buy)
A 2022-05-18   Sorrento Therapeutics, Inc. 4 A-Award --D 350000.0000 350000.0000 1 0000850261 Stock Option (right to buy)
A 2022-05-04   DELCATH SYSTEMS, INC. 4 A-Award --D 9000.0000 9000.0000 1 0000872912 Stock Options
A 2021-11-18   Sorrento Therapeutics, Inc. 4 A-Award --D 100000.0000 100000.0000 1 0000850261 Stock Option (right to buy)
A 2021-08-05   DELCATH SYSTEMS, INC. 4 A-Award --D 9000.0000 9000.0000 1 0000872912 Stock Option (right to buy)
A 2020-11-23   DELCATH SYSTEMS, INC. 4 A-Award --D 20000.0000 20000.0000 1 0000872912 Stock Option (right to buy)
A 2020-06-18   SPECTRUM PHARMACEUTICALS INC 4 A-Award --D 60000.0000 60000.0000 2 0000831547 Stock Option (Right to Buy)
A 2020-06-18   SPECTRUM PHARMACEUTICALS INC 4 A-Award --D 30000.0000 40000.0000 1 0000831547 Common Stock, $0.001 par value
A 2019-06-20   SPECTRUM PHARMACEUTICALS INC 4 A-Award --D 20000.0000 20000.0000 2 0000831547 Stock Option (Right to Buy)
A 2019-06-20   SPECTRUM PHARMACEUTICALS INC 4 A-Award --D 10000.0000 10000.0000 1 0000831547 Common Stock, $0.001 par value
A 2017-09-22   Altimmune, Inc. 4 A-Award --D 62500.0000 62500.0000 2 0001326190 Stock Options (option to buy)
A 2017-09-22   Altimmune, Inc. 4 A-Award --D 62500.0000 62500.0000 1 0001326190 Stock Options (option to buy)
A 2017-05-04   Altimmune, Inc. 4 A-Award --D 18727.0000 18727.0000 2 0001326190 Stock Option (option to buy)
A 2017-05-04   Altimmune, Inc. 4 A-Award --D 178595.0000 178595.0000 1 0001326190 Stock Option (option to buy)
A 2007-10-09   HEALTHCARE ACQUISITION CORP 4 A-Award --I 20000.0000 20000.0000 1 0001326190 Stock Option (Right to Buy)
A 2007-05-31   AFFYMAX INC 4 A-Award --D 2500.0000 2500.0000 1 0001158223 Stock Option (Right to Buy)
A 2006-12-20   AFFYMAX INC 4 C-Conversion --I 496950.0000 1159551.0000 2 0001158223 Common Stock
D 2006-12-20   AFFYMAX INC 4 C-Conversion --D 662601.0000 0.0000 3 0001158223 Series C Convertible Preferred Stock
D 2006-12-20   AFFYMAX INC 4 C-Conversion --D 496950.0000 0.0000 4 0001158223 Series D Convertible Preferred Stock
A 2006-12-20   AFFYMAX INC 4 C-Conversion --I 662601.0000 662601.0000 1 0001158223 Common Stock
A 2006-12-14   AFFYMAX INC 4 A-Award --D 7500.0000 7500.0000 1 0001158223 Stock Option (Right to Buy)
A 2005-05-25   ADVANCIS PHARMACEUTICAL CORP 4 A-Award --D 20000.0000 20000.0000 1 0001161924 Stock Option (Right to Buy)
A 2004-06-03   ADVANCIS PHARMACEUTICAL CORP 4 A-Award --D 20000.0000 20000.0000 1 0001161924 Stock Option (Right to Buy)
A 2003-10-22   ADVANCIS PHARMACEUTICAL CORP 4 C-Conversion --I 2428549.0000 2428549.0000 1 0001161924 Common Stock
D 2003-10-22   ADVANCIS PHARMACEUTICAL CORP 4 C-Conversion --I 4444444.0000 0.0000 2 0001161924 Series E Convertible Preferred Stock
A 2003-10-16   ADVANCIS PHARMACEUTICAL CORP 4 A-Award --D 13661.0000 13661.0000 1 0001161924 Stock Option (right to buy)
- -   AFFYMAX INC 3 - --I 1 0001158223 Series C Convertible Preferred Stock
- -   DELCATH SYSTEMS, INC. 3 - --- 1 - -
- -   AFFYMAX INC 3 - --I 2 0001158223 Series D Convertible Preferred Stock
- -   SPECTRUM PHARMACEUTICALS INC 3 - --- 1 - -
- -   Sorrento Therapeutics, Inc. 3 - --- 1 - -
- -   Vickers Vantage Corp. I 3 - --D 1 0001820190 Nonstatutory Stock Option (right to buy)
- -   ADVANCIS PHARMACEUTICAL CORP 3 - --D 2 0001161924 Stock Options (right to buy)
- -   HEALTHCARE ACQUISITION CORP 3 - --I 3 0001326190 Stock Option (right to buy)
- -   HEALTHCARE ACQUISITION CORP 3 - --I 1311451.0000 1 0001326190 Common Stock
- -   HEALTHCARE ACQUISITION CORP 3 - --I 2 0001326190 8% Convertible Notes
- -   Altimmune, Inc. 3 - --- 1 - -
- -   CANCER GENETICS, INC 3 - --D 2 0001349929 Stock Option (right to buy)
- -   CANCER GENETICS, INC 3 - --D 1 0001349929 Stock Option (right to buy)
- -   ADVANCIS PHARMACEUTICAL CORP 3 - --I 1 0001161924 Series E Convertible Preferred Stock
- -   HEALTHCARE ACQUISITION CORP 3/A - --I 3 0001326190 Stock Option (right to buy)
- -   HEALTHCARE ACQUISITION CORP 3/A - --I 2 0001326190 8% Convertible Notes
- -   HEALTHCARE ACQUISITION CORP 3/A - --I 1320087.0000 1 0001326190 Common Stock
- -   HEALTHCARE ACQUISITION CORP 3/A - --I 3 0001326190 Stock Option (right to buy)
- -   HEALTHCARE ACQUISITION CORP 3/A - --I 2 0001326190 8% Convertible Notes
- -   HEALTHCARE ACQUISITION CORP 3/A - --I 1320065.0000 1 0001326190 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016